D'Orazio & Associates, Inc. Novartis Ag Transaction History

D'Orazio & Associates, Inc.

$703 Million
Q3 2024

A detailed history of D'Orazio & Associates, Inc. transactions in Novartis Ag stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 3,862 shares of NVS stock, worth $382,260. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,862

Previous 3,792 1.85%

Holding current value

$382,260

Previous $403,000 10.17%

% of portfolio

0.06%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$106.13 - $120.89 $7,429 - $8,462	70 Added 1.85%	3,862 $444,000
Q2 2024 Aug 07, 2024	BUY	$92.57 - $107.37 $2,777 - $3,221	30 Added 0.8%	3,792 $403,000
Q1 2024 May 08, 2024	BUY	$95.27 - $108.47 $12,861 - $14,643	135 Added 3.72%	3,762 $363,000
Q4 2023 Feb 07, 2024	BUY	$92.27 - $101.54 $41,336 - $45,489	448 Added 14.09%	3,627 $366,000
Q3 2023 Oct 10, 2023	SELL	$94.73 - $105.13 $23,114 - $25,651	-244 Reduced 7.13%	3,179 $323,000
Q2 2023 Aug 04, 2023	BUY	$92.52 - $104.91 $47,462 - $53,818	513 Added 17.63%	3,423 $345,000
Q1 2023 Apr 21, 2023	SELL	$80.03 - $92.81 $21,127 - $24,501	-264 Reduced 8.32%	2,910 $267,000
Q4 2022 Jan 25, 2023	BUY	$75.55 - $92.52 $239,795 - $293,658	3,174 New	3,174 $0
Q4 2021 Feb 07, 2022	SELL	$79.7 - $88.13 $45,907 - $50,762	-576 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$81.78 - $95.14 $47,105 - $54,800	576 New	576 $47,000
Q4 2017 Feb 06, 2018	SELL	$72.33 - $77.64 $8,173 - $8,773	-113 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $8,377 - $8,731	113	113 $10,000

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.

Account

D'Orazio & Associates, Inc. Novartis Ag Transaction History